title: Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension.
authors.affiliation: Department of Cardiology, Gil Heart Center, Gachon Medical School, Incheon, Korea. kwangk@gilhospital.com
authors.forename: Kwang Kon
authors.initials: KK
authors.lastname: Koh
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Quon
authors.forename: Sang Jin
authors.initials: SJ
authors.lastname: Lee
authors.forename: Seung Hwan
authors.initials: SH
authors.lastname: Han
authors.forename: Jeong Yeal
authors.initials: JY
authors.lastname: Ahn
authors.forename: Jeong-a
authors.initials: JA
authors.lastname: Kim
authors.forename: Wook-Jin
authors.initials: WJ
authors.lastname: Chung
authors.forename: Yonghee
authors.initials: Y
authors.lastname: Lee
authors.forename: Eak Kyun
authors.initials: EK
authors.lastname: Shin
mesh_terms: D052242:Adiponectin / Q000097:blood; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D008076:Cholesterol, HDL / Q000097:blood; D004095:Dihydropyridines / Q000627:therapeutic use*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000503:physiopathology*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D020738:Leptin / Q000097:blood; D009596:Nitrophenols / Q000627:therapeutic use*; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D010919:Placebos; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology
chemical_list: D052242:Adiponectin; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D008076:Cholesterol, HDL; D004095:Dihydropyridines; D020738:Leptin; D009596:Nitrophenols; D009943:Organophosphorus Compounds; D010919:Placebos; C066425:efonidipine